The field of engineering the immune system through gene and cell-based editing is among the most innovative frontiers in modern medicine. Combining advanced genetic engineering, cellular therapy, and immunology, researchers are discovering new ways to modulate immune responses, strengthen immune defenses against cancer, autoimmune diseases, and infectious diseases.
The key sessions in the (CGTWC) 2026 address CAR-T and TCR design, gene-modified immune cells, and translational science linking discovery with clinical practice.
The Translational Medicine Conference bridges scientific discoveries with real-world clinical applications and patient care.